Myoptechs, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Myoptechs, Inc. - overview
Established
2022
Location
Columbus, OH, US
Primary Industry
Medical Devices & Equipment
About
Based in Ohio, US, and founded in 2022, Myoptechs, Inc. is an ophthalmic medical device company offering eye contact lenses that help patients suffering from myopia slow down their progression. As of 2024, the company is headed by its CEO Paul Grimm. In August 2024, the firm raised USD 1.
27 million in Seed funding from investors Rev1 Ventures and WS Investment Company. The company offers a solution designed to slow the progression of myopia (nearsightedness) while providing clear vision. Myoptechs’ primary offering is a soft contact lens featuring the patent-pending Faceted Optical System™, which is specifically engineered to manage myopia progression. This design aims to provide clearer vision and myopic defocus—an optical signal known to help slow the progression of myopia.
Current Investors
WS Investments, Rev1 Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services
Website
www.myoptechs.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.